StockIQ.techTonix Pharmaceuticals Holding Corp. (TNXP) Stock Analysis
Free AI-powered analysis and research for Tonix Pharmaceuticals Holding Corp. stock
Sector: Healthcare
Full TNXP report
Tonix Pharmaceuticals Holding Corp. (TNXP) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze TNXP Now →📰 Latest Update
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
Wed, September 2, 2026 at 1:38 PM UTC 2 min read
TNXP reported $11.0 million in net revenue from its Tonmya® product for the second quarter of 2026, indicating a strong performance in its commercial launch. This revenue figure is significant for investors as it demonstrates the product's market acceptance and potential for future growth, reinforcing the company's financial stability and strategic positioning in the pharmaceutical sector. Investors may view this positive trend as a catalyst for further stock appreciation.